# Bismillah ir-Rahman ir-Rahim

# R0619 -- SEAT REPORT -- F-S05-55

**Chronological Index:** 481 of 995  
**Date:** 2026-08-10  
**Section:** IX. Multi-Model Audit Trail (dispatches, seat reports, councils, ledgers)  
**Source File:** F-S05-55_SEAT_REPORT.md  
**Source Format:** md  
**SHA-256:** `81ec436ea342934ed6a916d82c4790706555bc9a47631507675fc01d32ff0cad`  

---

## R0619 · SEAT REPORT -- F-S05-55

- section: IX. Multi-Model Audit Trail (dispatches, seat reports, councils, ledgers)
- source_file: F-S05-55_SEAT_REPORT.md
- source_format: md
- text_sha256: 81ec436ea342934ed6a916d82c4790706555bc9a47631507675fc01d32ff0cad

# SEAT REPORT -- F-S05-55

**Seat:** S05-OPUS5-BIOMEDICAL
**Round:** R14 (Convergence)
**Artifact:** XZ Protocol v0.55 DRAFT CANDIDATE
**Model:** Claude Opus 5 | producer family | **advisory, non-carrying, non-binding**
**Quantum:** n=3, l=3, ml=3, ms=-1/2 (M-shell, f-orbital, Biomedical Fractal, fresh)
**Date:** 2026-08-10

## VERDICT

**HALT (advisory).** Two Class A findings in the v0.55 amendment entry's
defect register. Zero Class A in the body (Sections 0-26): all three R13
body-locus defects are genuinely repaired and the repairs are real on
shipped bytes.

0 CRITICAL / 3 HIGH / 4 MEDIUM / 7 LOW.
Class: 2 A / 3 B / 1 C / 4 D / 4 E.

This seat is producer-family. Nothing here counts toward FB-7b or FB-8.

---

## BASELINE

| Item | Result |
|---|---|
| PROTOCOL.txt sha256 | `74dc8101...4c39` -- matches PACKET_MANIFEST and DISPATCH |
| BUILD_GATES.txt sha256 | `afc03768...6aeb` -- matches PACKET_MANIFEST and DISPATCH |
| SEAL_HISTORY.txt sha256 | `61cfd4fe...9ed7` -- matches the manifest line for `HISTORY.sha256` |
| Shipped manifest members | 3 of 16 ship; 3 of 3 verify byte-identical |
| 55 ENTRY seals | all recomputed, all match |
| FULL_SECTION_27 | `41a314e7...b723` recomputed, matches |
| PRIOR_HISTORY | `123550f5...98bc` re-derived by faithful replay of `derive_prior_history`, matches shipped |
| Text-only gates | [2] [2b] [2c] [2e] [2f] [2g] [2h] [9] [9a] [9b] [9c] [9d] [9e] [9f] [10b] all GREEN on shipped bytes |
| Gate categories | 29 (v0.54: 25) -- the four new gates are present |
| `check()` call sites | 72 (v0.54: 62) |

Computational baseline (12 .py + trust roots) does not ship; per dispatch it is
independently confirmed and prose audit is primary. Every claim depending on
those files is flagged as a verification limit in section VI.

---

## VERIFIED CLEAN -- the R13 repairs landed

All eight declared body repairs [a]-[h] are present at their claimed loci:

- [a] Line 1 title reads `# XZ Protocol v0.55` -- **R13 Finding 1 CLOSED**
- [b] `**Version:** 0.55,`
- [c] Status line self-reference v0.55, provenance `v0.54 R13 audit` -- **R13 Finding 2 CLOSED at the locus**
- [d] Section 0.1 "fifty-five amendment entries, v0.1 through v0.55"; 55 entry lines confirmed
- [e] Section 22.2 "v0.1 through v0.53" -> "v0.1 through v0.54"
- [f] Section 22.3 lineage reads "v0.38-v0.55" -- **real diff, not a no-op** (Prediction 4 clears)
- [g] Section 25 FB-7b row reads "PENDING RE-CARRY v0.55"; R12/R13 trajectory present -- **R13 Finding 3 CLOSED**
- [h] Section 0.1 "PENDING RE-CARRY on v0.55 bytes"

Standing-boundary count: declared 33 == `[ENUMERATED: 33 items]` == paren-aware
enumeration 33. Three-way agreement holds. The retired item ([3a] fb_spec) is
absent from the list; the two new items are present at positions 29 and 33.

Standing-rules sweep: 0 U+2013/2014/2015, 0 smart quotes, 0 "Bayyinah Enterprise"
with space, all severity tokens uppercase, no ordinal-recurrence hits.

EXTERNAL-count inflation reported at R13 (F-S05-54-11: declared 2, `[9c]` counted 3)
is resolved. `[9c]` now counts exactly 2 and the entry declares 2.

---

## FINDINGS

### F-S05-55-01 -- HIGH -- Class A

**Locus.** Section 27, v0.55 entry, defect register item (3).

**Substance.** Item (3) cites two finding IDs (`F-S01-54-03 / F-S03-54-03`) and
declares "3-seat convergence". Three locations on shipped bytes give three
different values for the same quantity:

| Locus | Claim |
|---|---|
| Register item (3) | 2 cited IDs, "3-seat convergence" |
| v0.55 narrative paragraph | "Third finding (3/5 seats)" |
| Section 25 FB-7b row | "3 Opus 5 advisory seats HALTed advisory (same title and status defects **plus FB-7b row stale**)" -- which with the carrying seat gives 4 |

The packet's own AUDIT_CONTEXT.txt names four IDs for this defect
(`F-S01-54-03, F-S02-54-02, F-S03-54-03, F-S05-54-02`). The correct value is
4-seat; the register states 3 and enumerates 2. The count and the enumeration
cannot both be right and neither matches the body.

**Disposition.** Correction required. Item (3) must cite
`F-S01-54-03 / F-S02-54-02 / F-S03-54-03 / F-S05-54-02` and declare 4-seat
convergence; the narrative "3/5 seats" must be corrected to 4/5.

**Cross-reference.** F-S05-55-02 (same mechanism, adjacent locus);
F-S05-55-08 (the gate gap that let it through); Prediction 1 of AUDIT_CONTEXT.txt,
confirmed; historical precedent correction (as) at v0.44.

- Fractal Cube: Layer 1, **C1** (finding-ID cross-references, current entry) -- a removed face-centre cell
- Enzyme: **PROVENANCE** (zero occurrences in the entry; see F-S05-55-10)
- Replication phase: **Phase 3** (register composition)
- Orbital: 3f, ml=3, ms=-1/2
- Biomedical reading: the gates recruited three dead-space cells at Layer 1 rows A and B; the lesion migrated one cell to the right, into column C, which was never gated. Filtration improved at the treated sites and the pathology relocated.

### F-S05-55-02 -- HIGH -- Class A

**Locus.** Section 27, v0.55 entry, defect register items (2) and (3).

**Substance.** Finding-ID transposition. Item (2) (status-provenance defect)
cites `F-S05-54-02`. In the S05 R13 seat report, `F-S05-54-02` is the **FB-7b
row** finding; the status-provenance finding is `F-S05-54-03`. AUDIT_CONTEXT.txt
independently gives the same mapping. Item (2) therefore attributes to the
status defect an ID belonging to the FB-7b defect, and item (3) -- where that ID
belongs -- omits it. A single transposition produces both errors and explains
the residual "3" in F-S05-55-01.

**Evidence provenance (disclosed).** The byte-level inconsistencies in
F-S05-55-01 were formed from packet bytes alone. This finding was then anchored
against the S05 R13 seat report, which is held outside the producer's control.
Consulting it is a Section 22.2 external anchor, not prior-round contamination;
it was consulted after the byte work, and it is named here so the reader can
weigh it.

**Disposition.** Correction required. Item (2): replace `F-S05-54-02` with
`F-S05-54-03`. Item (3): add `F-S05-54-02` and `F-S02-54-02`.

**Cross-reference.** F-S05-55-01; F-S05-55-08; PMD v1.8 M1.6 (codification-cycle
self-error); AX-SH Axiom 2.

- Fractal Cube: Layer 1, **C1**
- Enzyme: **PROVENANCE**
- Replication phase: **Phase 3**
- Orbital: 3f, ml=3, ms=-1/2
- Biomedical reading: the producer's repair pipeline is byte-driven at Phase 2 and memory-driven at Phase 3. The four new gates are Phase-2 instruments. Phase 3 remains unenzymed.

### F-S05-55-03 -- HIGH -- Class D (undisclosed)

**Locus.** build.py `# [2f]` status-provenance gate; v0.55 register item (2).

**Substance.** Gate [2f] does not close the class it is credited with closing.
It asserts only `prov_ver < VERSION`. The regex captures the round number
(`group(2)`) and never uses it. Mutation probes on copies:

| Probe | Status-line text | [2f] result |
|---|---|---|
| Baseline | `repair build from v0.54 R13 audit` | PASS |
| A | `repair build from v0.52 R11 audit` -- the exact string R13 found stale, 5/5 seats | **PASS** |
| B | `repair build from v0.54 R99 audit` | **PASS** |

Probe A is decisive: the defect the gate was added to prevent survives the gate.
Any provenance version below 0.55, and any round number whatsoever, passes. The
gap is not in the standing-boundary list, so it is an undisclosed gate limitation;
under Section 22.3 an undisclosed defect is Class B, and this finding sits on that
line. It is recorded as Class D because register item (2)'s description of what
[2f] checks is literally accurate -- the overclaim is in "CLOSED", not in the tag.

**Disposition.** Gate improvement required. Assert `prov_ver == VERSION - 1` and
`prov_round == PRIOR_ROUND`, both derived from single declared constants.

**Cross-reference.** AUDIT_CONTEXT.txt Prediction 2, confirmed live;
standing boundary 24 ([2c] arity-two), unretired.

- Fractal Cube: Layer 2, **A1** (gate layer, identity, current entry)
- Enzyme: **COMPUTED** (tag names a section that exists and fires but under-checks)
- Replication phase: Phase 5b (terminal recomputation), incompletely implemented
- Orbital: 3f, ml=3, ms=-1/2
- Biomedical reading: the enzyme binds the substrate but has the wrong active site. Coverage counted, catalysis absent.

### F-S05-55-04 -- MEDIUM -- Class D (undisclosed)

**Locus.** build.py `# [2g]` FB-7b row version gate.

**Substance.** [2g] searches the whole protocol for `PENDING RE-CARRY v<x>`; if
found, it requires at least one occurrence in the body and requires every body
occurrence to equal VERSION. Section 27 carries five historical
`PENDING RE-CARRY` tokens, so the outer condition is permanently true. When FB-7b
transitions to RESOLVED and the body token disappears, the gate takes the
`check(False, "PENDING RE-CARRY found in body")` branch. Probe C (replace the body
token with `RESOLVED v0.55`) returns FAIL.

The build therefore breaks at exactly the moment the protocol reaches its target
state.

**Disposition.** Gate improvement required. Gate the FB-7b row status token as
`(PENDING RE-CARRY|RESOLVED)` and apply version parity only in the PENDING branch.

**Cross-reference.** AUDIT_CONTEXT.txt Prediction 2 (edge case named, now confirmed);
F-S05-55-03.

- Fractal Cube: Layer 2, A3 | Enzyme: COMPUTED | Phase 5b | 3f, ml=3, ms=-1/2
- Biomedical reading: an autoimmune gate -- it will attack the healthy state.

### F-S05-55-05 -- MEDIUM -- Class B

**Locus.** Section 27, v0.55 entry, register header.

**Substance.** The header reads "from R13 five-seat audit, 5 Class A items +
additional findings". No available referent yields 5. AUDIT_CONTEXT.txt names
four R13 defect groups; the register holds six items; the per-seat Class A counts
in the R13 table sum to 14; the distinct body-locus Class A defects number 3.
The figure is unresolvable from shipped bytes and from the packet.

**Disposition.** Correction required: state the referent explicitly (distinct
defects, register items, or per-seat findings) and recompute.

**Cross-reference.** F-S05-55-01; R11 (producer attention gradient) -- the header is
composed last.

- Fractal Cube: Layer 1, B1 | Enzyme: none (untagged count) | Phase 3 | 3f, ml=3, ms=-1/2

### F-S05-55-06 -- MEDIUM -- Class B

**Locus.** Section 27, v0.55 entry, register item (5); standing boundary item 29.

**Substance.** Item (5) reads: "class-to-severity mapping
(A=CRITICAL/HIGH, B=MEDIUM, C=LOW, D=LOW, E=INFORMATIONAL) **not defined on
shipped bytes**". The sentence prints the mapping and is itself shipped and sealed
under ENTRY_v0.55. The claim is false on the bytes that carry it. Standing
boundary 29 repeats the assertion.

Counter-reading, stated for the reader's judgement: "defined" may be intended as
"normatively defined in the governance layer", and a descriptive parenthetical in
an amendment entry is not normative. Under that reading the claim is true and the
defect is drafting imprecision. The report records the finding at MEDIUM rather
than HIGH on that account.

**Disposition.** Either define the mapping normatively in Section 22.3 and retire
boundary 29, or remove the parenthetical. Not both.

**Cross-reference.** F-S05-54-09 (R13, mapping unstated); R5 (self-similarity) --
the correction exhibits the class it describes.

- Fractal Cube: Layer 1, A3 | Enzyme: ASSERTED | Phase 3 | 3f, ml=3, ms=-1/2

### F-S05-55-07 -- MEDIUM -- Class B

**Locus.** Section 27, v0.55 entry, register item (3): "standing boundary item 29 retired".

**Substance.** The reference is ordinal into a list that the same entry reorders.
On v0.55 bytes, boundary item 29 is `class-to-severity mapping undefined on
shipped bytes (F-S01-54-04)` -- a live boundary newly added by this same entry.
A reader following the citation finds the opposite of what it asserts. The retired
item (`[3a] fb_spec omits FB-7b locus assertion`) held position 29 only on v0.54
bytes and is unnamed in the entry.

**Disposition.** Correction required: name retired boundaries by their text or by a
stable identifier, never by position.

**Cross-reference.** Standing boundary 20 (no boundary-retirement mechanism) --
which this finding shows is not merely a missing convenience but an active
ambiguity source.

- Fractal Cube: Layer 1, C1 | Enzyme: none | Phase 3 | 3f, ml=3, ms=-1/2

### F-S05-55-08 -- LOW -- Class D

**Locus.** build.py `# [9f]`, `# [10b]`.

**Substance.** Layer 1 cell C1 -- finding-ID cross-references -- is nominally gated
and semantically vacuous. [9f] checks that parsed register items equal declared
markers (6 == 6) and that no ID carries two severities; [10b] checks cross-item ID
uniqueness. Neither touches attribution or convergence arithmetic. Probes on copies,
all of which leave both gates unchanged at 6/6:

| Probe | Result |
|---|---|
| Convergence count "3-seat" -> "97-seat" | PASS |
| Convergence count "3-seat" -> "0-seat" | PASS |
| Fabricated ID `F-S99-54-99` substituted into item (3) | PASS |

A finding ID naming a seat that never existed survives the register gates.
F-S05-55-01 and -02 live in this cell for that reason.

**Disposition.** Gate improvement required. Ship a machine-readable findings index
(or the seat reports themselves) in the packet; assert that every register-cited ID
resolves in the index and that each declared convergence count equals the cardinality
of its cited ID set. This creates the first PROVENANCE enzyme.

**Cross-reference.** F-S05-55-01, -02, -10; R2 (ungated band concentration).

- Fractal Cube: Layer 2, C1 | Enzyme: PROVENANCE, unimplemented | Phase 3 | 3f, ml=3, ms=-1/2

### F-S05-55-09 -- LOW -- Class C

**Locus.** build.py `# [9e]`, `# [11]`.

**Substance.** [9e] cardinal-range consistency fired zero checks on the v0.55 entry
(no `N consecutive ... (v0.X through v0.Y)` construction present). [11] contains no
`check()` call at all -- it prints coverage figures and cannot fail. Standing
boundary 23 ([9e] silent vacuity) is confirmed live for a second consecutive round.

**Disposition.** DISCLOSED (boundary 23 covers [9e]). [11]'s check-free status is not
covered by any boundary; recommend either adding a coverage-floor assertion or
disclosing it.

**Cross-reference.** F-S05-54-08 (R13, same observation).

- Fractal Cube: Layer 2, B2 | Enzyme: COMPUTED, vacuous | Phase 4 | 3f, ml=3, ms=-1/2

### F-S05-55-10 -- LOW -- Class D

**Locus.** Section 27, v0.55 entry, EXTERNAL tags; build.py `# [9c]`.

**Substance.** EXTERNAL count is 2 and the declared value matches. One of the two,
`[EXTERNAL: R13 seat reports]`, names artifacts that do not ship in the packet.
[9c]'s existence check only fires when the token after `[EXTERNAL:` carries a
`.md/.py/.json/.pdf/.txt` extension, so it does not fire here. The entire
finding-ID register therefore rests on an external anchor that no reader of the
packet can open -- which is precisely why F-S05-55-01/-02 were undetectable from
shipped bytes alone.

**Disposition.** Ship the seat reports or a findings index (converges with F-S05-55-08).

**Cross-reference.** F-S05-54-11 (R13, EXTERNAL inflation, now resolved -- the
count is correct; the anchor is still unopenable).

- Fractal Cube: Layer 3, C1 | Enzyme: EXTERNAL | Phase 3 | 3f, ml=3, ms=-1/2

### F-S05-55-11 -- LOW -- Class E

**Locus.** Section 22.

**Substance.** Subsections ship in the order 22.1, 22.3, 22.2. Repair [e] cites
"Section 22.2" and repair [f] cites "Section 22.3" in the order the sections *should*
appear, which is not the order they *do* appear.

**Disposition.** Correction recommended (body reorder, not a claim defect).

### F-S05-55-12 -- LOW -- Class E

**Locus.** Section 0.1.

**Substance.** Section 0.1 declares the Section 25 FB-7b row the "single source of
truth; no duplicate rationale maintained here", then carries a "Carry status:"
paragraph duplicating the row's v0.3 / v0.4 / v0.5 / v0.31 trajectory, and separately
restates the current PENDING RE-CARRY status. Substrate-of-record uniqueness is
declared and not held.

**Disposition.** DISCLOSED / correction recommended.

### F-S05-55-13 -- LOW -- Class E

**Locus.** DISPATCH_AND_LENS.txt; FIVE_LAYER_ARCHITECTURE.txt.

**Substance.** Three dispatch-side defects, none affecting the artifact:

1. Quantum numbers `n=3, l=3` are impossible under the dispatch's own Model IV
   (`l <= n-1`; an f-orbital requires n>=4). Unchanged from R13 (F-S05-54-12);
   the correction was not absorbed.
2. Model V directs the seat to a `LENS_[name].txt` file; no such file ships. The
   lens is inlined in DISPATCH_AND_LENS.txt instead.
3. BIO-4 asks about "27 L1 cells"; Model I defines Layer 1 as 9 cells and the cube
   as 27 across three layers.

**Disposition.** Correction recommended in the R15 dispatch template.

### F-S05-55-14 -- LOW -- Class E

**Locus.** AUDIT_CONTEXT.txt, "THE HURST EXPONENT"; DISPATCH_AND_LENS.txt BIO-3.

**Substance.** The claim "Using the R/S method on R7-R13: H ~ 1.0" is not computable.
The series is constant (all 1). The mean-adjusted cumulative deviation range R = 0
and the standard deviation S = 0, so R/S is 0/0 and H is undefined, not 1.0. The
same holds with R14 appended.

**Disposition.** Retract the numeric claim; report persistence descriptively.

**Cross-reference.** See section IV below for the substitute statistic.

---

## IV. BIOMEDICAL FRACTAL LENS -- MEASURED VALUES

### BIO-1 Dead space

| Quantity | v0.54 | v0.55 | Delta |
|---|---|---|---|
| Document | 343,991 chars | 352,368 chars | +8,377 |
| Body (Sections 0-26) | 104,292 | 104,701 | +409 |
| Section 27 (ungated) | 239,699 (69.7%) | 247,667 (70.3%) | +7,968 (+0.60 pp) |
| Semantic-gate coverage of body | -- | 30,250 / 104,701 = 28.9% | -- |
| Whole-document gated share | -- | 8.6% | -- |
| **Dead-space fraction (document)** | -- | **91.4%** | -- |

**Did the four new gates reduce dead space measurably? No.** They added three
body-locus checks worth a few hundred characters of newly covered text, while the
v0.55 entry added 7,968 characters of ungated Section 27 prose. Net dead space rose
by 0.60 percentage points and by 7,968 characters absolute. Each repair round
enlarges the ungated band faster than its gates shrink it. The v0.55 entry's own
coverage framing is not contradicted on bytes -- the protocol makes no numeric
coverage claim -- but the FIVE_LAYER_ARCHITECTURE expectation ("the dead-space
fraction should have decreased") is falsified.

### BIO-2 Enzyme-type distribution (v0.55 entry, 27 tagged claims)

| Enzyme | Count | Share | Gate that verifies it |
|---|---|---|---|
| COMPUTED | 10 | 37.0% | [9c] -- section-existence only |
| DIFF-VERIFIED | 9 | 33.3% | **none** (`DIFF-VERIFIED` appears 0 times in build.py) |
| ASSERTED | 5 | 18.5% | none by definition |
| EXTERNAL | 2 | 7.4% | [9c] -- file-existence, does not fire here |
| ENUMERATED | 1 | 3.7% | [2h] -- genuine three-way check |
| PROVENANCE | 0 | 0.0% | -- |
| COUPLED | 0 | 0.0% | -- |

**Which type covers most text?** COMPUTED (10 tags), and it is the only type
attached to the four new gates.

**Which has the highest false-positive rate?** DIFF-VERIFIED, unambiguously. Nine
claims -- a third of all tagged claims -- carry a verification label that no gate
implements and that no reader can check, because v0.54 bytes do not ship. The
producer's own register item (6) records a confirmed false positive of this exact
type at v0.54 (repair [d] tagged DIFF-VERIFIED on a no-op), and R13 F-S05-54-04
recorded a second (v0.53 and v0.54 both claiming DIFF-VERIFIED for the identical
Section 22.3 change). Two confirmed false positives, zero verification capability,
33.3% of the tag mass.

**The structurally decisive number is PROVENANCE = 0.** The Enzyme-Substrate model
defines PROVENANCE as the enzyme for tracing finding IDs to source reports. The
v0.55 entry contains fifteen finding-ID cross-references and four convergence counts.
Not one carries the tag. The R14 Class A findings live in the enzyme class with zero
occurrences -- the lesion is exactly where the metabolism is absent.

### BIO-3 Hurst exponent

Class A binary series R7-R14: `1, 1, 1, 1, 1, 1, 1, 1` (R14 = 1, this report).

R/S computation: mean = 1.0; cumulative mean-adjusted deviations all 0;
R = max - min = 0; S = 0. **H is undefined (0/0), not 1.0.** A constant series has
no rescaled range. The handoff's "H ~ 1.0" is an artifact of assuming the answer.
Appending R14 = 1 changes nothing; appending R14 = 0 would have made the series
non-constant and H computable for the first time.

Substitute statistic, which is well-defined: 8 of 8 rounds since R7 produced at
least one Class A. Laplace-smoothed P(Class A at R15) = 9/10 = **0.90**.

**Does the series exit the persistent regime?** No, and it cannot be shown to have
exited it by this estimator until a zero appears. The regime question is
unanswerable by R/S on this data and should be replaced by the recurrence fraction
and the defect-class-migration test, both of which are computable.

### BIO-4 Fractal Cube cell accounting

Cube: 3 layers x 9 cells = 27. Layer 1 (claims) is the diagnostic layer.

| Layer 1 cell | Gate | Effective on v0.55? |
|---|---|---|
| A1 identity, current entry | [2], [2e], [2f] | **partial** -- [2e] proven effective by probe; [2f] proven ineffective (F-S05-55-03) |
| B1 counts | [9], [9f], [2h] | full -- [2h] proven effective by probe |
| C1 finding-ID cross-references | [9f] regex | **vacuous** -- fabricated IDs survive (F-S05-55-08) |
| A2 append-only preservation | [3a], [9b] | full -- 55/55 seals verified |
| B2 historical count consistency | [9e] | **vacuous** -- 0 checks fired |
| C2 historical ID provenance | [3] | full (files absent; gate sound) |
| A3 FB status assertions | [2c], [2g] | **partial** -- [2c] arity-two (boundary 24); [2g] fragile (F-S05-55-04) |
| B3 test/code partition | [5], [8] | full |
| C3 seal/hash chain | [9b] | full -- PRIOR_HISTORY re-derived |

Nominal Layer-1 coverage 9/9. **Effective coverage 6.0/9 = 66.7%** (5 full,
2 partial at 0.5, 2 vacuous).

**The four new gates cover three cells, not four.** [2e] and [2f] both land in A1;
[2g] lands in A3; [2h] lands in B1. The dispatch's "four cells" framing counts gates,
not cells. Column C -- reference and cross-reference -- received nothing, and that is
where both Class A findings sit.

Fractal dimension, auditor-constructed (axes and retention rule stated, not derived
from shipped bytes): counting cells covered by a non-vacuous gate across all three
layers gives 11 of 27 retained, D = log(11)/log(3) = **2.183**, against the idealized
Menger sponge D = log(20)/log(3) = 2.727 and the solid cube D = 3.000.

**Is the dead-space fraction converging to a fixed point?** Not yet. The measurable
series (Section 27 share) is 69.7% -> 70.3%, moving away from the target, and its
driver -- entry length per repair round -- has no ceiling. A fixed point exists only
if entry growth is bounded; nothing in the protocol bounds it.

### BIO-5 Boundary accumulation

Declared counts by version: v0.38 = 20, v0.42 = 22, v0.43 = 23, v0.44 = 24,
v0.45 = 25, v0.46 = 27, v0.47 = 29, v0.48 = 31, v0.49-v0.53 = 31, v0.54 = 32,
v0.55 = 33.

- v0.38 -> v0.48: +11 over 10 versions = **1.10 per version**
- v0.48 -> v0.55: +2 over 7 versions = **0.29 per version**

**Growth is decelerating.** This is healthy-ceiling behaviour, not pathological
complexity accumulation.

**Recorded retraction.** The R13 S05 report characterised boundary growth as
"accelerating (0.722/version across v0.36-v0.54)". That figure is a window average,
not a trend, and the characterisation was wrong: the within-window trend is
monotonically decelerating. R8 (boundary accumulation) as stated in the Predictive
Audit Paper -- "the accumulation rate is decelerating but nonzero" -- is correct and
the R13 seat's contradiction of it is retracted here.

### BIO-6 Renal / pulmonary

**Renal (filtration).** Improving, but not at the claimed rate. Four gates added;
three proven effective by mutation probe ([2e], [2g], [2h]); one proven ineffective
([2f], F-S05-55-03). Effective renal yield of the v0.55 intervention: 3/4 = 75%.
Two of nine Layer-2 cells remain vacuous. Gate categories 25 -> 29; static check
sites 62 -> 72.

**Pulmonary (oxygenation).** Still anemic, and the anemia is now load-bearing.
EXTERNAL count 2, unchanged from v0.54, and one of the two anchors names artifacts
absent from the packet. The R14 Class A could not be closed from shipped bytes; it
was closed only against a report held outside the producer's control. That is direct
empirical confirmation of Section 22.2's claim that external anchors are the sole
defense against self-consistent construction -- and a demonstration that the current
EXTERNAL count of 2 is below the level the register's own claims require.

---

## V. STRUCTURAL READING

**Failure-mode shift (R1) confirmed.** The three R13 defect classes are genuinely
gated. The defect did not recur; it migrated. R7-R11 seal-value literals ->
R12 count staleness -> R13 version-token staleness (Layer 1, rows A and B) ->
R14 finding-ID cross-references and convergence counts (Layer 1, column C). Each
migration lands one cell outside the newest gate's reach.

**Replication Fork phase shift.** FIVE_LAYER_ARCHITECTURE asked whether Phase 3
(register composition) carries the memory-driven error that Phase 2 carried at R13.
It does. The four new gates are Phase-2/5b instruments; Phase 3 has no enzyme.

**Generator level: L0.** The same class -- a value written from the producer's model
of the document rather than from the document -- is now on record at all four
patchable levels:

| Level | Instance |
|---|---|
| L1 entry text | v0.54 title version (R13) |
| L2 corrections / body repairs | v0.54 repair [d], DIFF-VERIFIED on a no-op (own register item 6) |
| L3 register dispositions | v0.55 items (2) and (3) (F-S05-55-01, -02) |
| L4 standing properties | v0.53 boundary count 31 vs 32 (R12) |

By the framework's own rule, a class present at L1 through L4 is generated at L0 and
no Level 1-4 patch will extinguish it. Four rounds of gate-adding have moved the
lesion without reducing it.

**The prescription is generation, not checking.** Checking is unbounded: each gate
covers one locus and the generator finds the next. Generation is bounded: derive
every version-dependent literal, count, and cross-reference from a single machine-
readable source at build time, so the producer cannot write them from memory at all.
The v0.55 gates are the last productive round of the checking strategy; the register
cross-references cannot be checked into correctness because the source they reference
does not ship.

---

## VI. VERIFICATION LIMITS

1. 13 of 16 manifest members (12 .py, trust roots) do not ship. All claims about
   test counts (186), file counts (14 normative), source-frame count (16), digests
   in Section 25, the manifest digest `40b9cad5...`, gates [3], [3a], [3b], [3c],
   [4], [5], [6], [7], [8], [12], and "grep -c v0.55 across 13 files = 13" are
   accepted on the dispatch's statement that the computational baseline is
   independently confirmed. Not verified by this seat.
2. All 9 DIFF-VERIFIED claims are unverifiable in principle from this packet: v0.54
   bytes do not ship. Only the post-state was confirmed at each locus.
3. HISTORY.sha256 ships inside the packet and is regenerable. All 55 entry seals,
   FULL_SECTION_27, and PRIOR_HISTORY verify, but this establishes internal
   consistency only. Standing boundary 31 (self-consistent resealing) is unresolved
   and unresolvable by this seat.
4. R13 seat reports do not ship. F-S05-55-02 was anchored against the S05 report
   held by this seat lineage; the S02 and S03 attributions rest on AUDIT_CONTEXT.txt,
   which is producer-supplied.
5. Producer-family seat. Nothing in this report counts toward FB-7b or FB-8.

---

## VII. PRESCRIPTIONS FOR v0.56

1. **Correct register item (2):** `F-S05-54-02` -> `F-S05-54-03`.
2. **Correct register item (3):** cite `F-S01-54-03 / F-S02-54-02 / F-S03-54-03 /
   F-S05-54-02`; declare 4-seat convergence; correct the narrative "3/5 seats" to 4/5.
3. **Ship a findings index** (JSON: seat, finding ID, severity, class, one-line
   substance) for every round cited by the register, and gate it: every register-cited
   ID must resolve, and every declared convergence count must equal the cardinality of
   its cited ID set. This is the first PROVENANCE enzyme and it closes Layer 1 cell C1.
4. **Fix [2f]:** assert `prov_ver == VERSION - 1` and `prov_round == PRIOR_ROUND`.
5. **Fix [2g]:** gate `(PENDING RE-CARRY|RESOLVED)` with version parity only in the
   PENDING branch, so FB-7b resolution does not break the build.
6. **Replace ordinal boundary references** with stable identifiers; name retired
   boundaries by text.
7. **Resolve the class-to-severity mapping** in Section 22.3 or delete the
   parenthetical from register item (5) and boundary 29.
8. **Restate or drop the register header's "5 Class A items"** with an explicit referent.
9. **Move from checking to generation** for version-dependent literals. This is the
   only prescription that addresses the L0 generator; items 3-7 are Level 2-3 patches
   and will hold only until the next migration.
10. **Correct the R15 dispatch template:** quantum numbers (`l <= n-1`), the missing
    `LENS_*.txt`, and the "27 L1 cells" / 9-cell discrepancy.

---

*Seat S05-OPUS5-BIOMEDICAL, R14, XZ Protocol v0.55. Advisory, non-carrying,
non-binding. HALT (advisory).*

---

# Bismillah ir-Rahman ir-Rahim
